Markers of endocrine sensitivity

Por Hayes, Daniel F
Publicado em 2008

Contribution of biomarkers to personalized medicine

Por Hayes, Daniel F
Publicado em 2010

OMICS-based personalized oncology: if it is worth doing, it is worth doing well!

Por Hayes, Daniel F
Publicado em 2013

Do All Patients with Breast Cancer Require Systemic Adjuvant Therapy?

Por Griggs, Jennifer J., Hayes, Daniel F.
Publicado em 2011

Personalized Medicine: Genomics Trials in Oncology

Por Hayes, Daniel F., Schott, Anne F.
Publicado no Trans Am Clin Climatol Assoc (2015)

Recent translational research: circulating tumor cells in breast cancer patients

Por Müller, Volkmar, Hayes, Daniel F, Pantel, Klaus
Publicado em 2006

Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting

Por McShane, Lisa M., Hayes, Daniel F.
Publicado em 2012

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

Por Simon, Richard M., Paik, Soonmyung, Hayes, Daniel F.
Publicado em 2009

A Model Citizen? Is Tamoxifen More Effective Than Aromatase Inhibitors if We Pick the Right Patients?

Por Hayes, Daniel F., Stearns, Vered, Rae, James, Flockhart, David
Publicado em 2008

ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors

Por Gilligan, Timothy D., Hayes, Daniel F., Seidenfeld, Jerome, Temin, Sarah
Publicado em 2010

Personalized medicine: risk prediction, targeted therapies and mobile health technology

Por Hayes, Daniel F, Markus, Hugh S, Leslie, R David, Topol, Eric J
Publicado em 2014

Drug Interactions and Pharmacogenomics in the Treatment for Breast Cancer and Depression

Por Henry, N. Lynn, Stearns, Vered, Flockhart, David A., Hayes, Daniel F., Riba, Michelle
Publicado em 2008

International Web-based consultation on priorities for translational breast cancer research

Por Dowsett, Mitch, Goldhirsch, Aron, Hayes, Daniel F, Senn, Hans-Joerg, Wood, William, Viale, Giuseppe
Publicado em 2007

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Ca...

Por Hammond, M. Elizabeth H., Hayes, Daniel F., Wolff, Antonio C., Mangu, Pamela B., Temin, Sarah
Publicado em 2010

Prediction of Postchemotherapy Ovarian Function Using Markers of Ovarian Reserve

Por Henry, N. Lynn, Xia, Rong, Schott, Anne F., McConnell, Daniel, Banerjee, Mousumi, Hayes, Daniel F.
Publicado em 2014

Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Est...

Por Wills, Shannon, Ravipati, Anita, Venuturumilli, Padmaja, Kresge, Cynthia, Folkerd, Elizabeth, Dowsett, Mitch, Hayes, Daniel F., Decker, David A.
Publicado em 2012

Promoting Quality and Evidence-Based Care in Early-Stage Breast Cancer Follow-up

Por Henry, Lynn N., Hayes, Daniel F., Ramsey, Scott D., Hortobagyi, Gabriel N., Barlow, William E., Gralow, Julie R.
Publicado no J Natl Cancer Inst (2014)

Oncology an evidence-based approach /

Por Chang, Alfred E., Ganz, Patricia A., Hayes, Daniel F., Kinsella, Timothy., Pass, Harvey I., Schiller, Joan H., Stone, Richard M., Strecher, Victor.
Publicado em 2006

CYP2D6 genotype and tamoxifen response

Por Rae, James M, Goetz, Matthew P, Hayes, Daniel F, Ingle, James N, Li, Lang, Storniolo, Anna Maria, Stearns, Vered, Flockhart, David A
Publicado em 2005

A Diet and Exercise Intervention during Chemotherapy for Breast Cancer

Por Djuric, Zora, Ellsworth, Jennifer S., Weldon, Anne L., Ren, Jianwei, Richardson, Caroline R., Resnicow, Kenneth, Newman, Lisa A., Hayes, Daniel F., Sen, Ananda
Publicado em 2011